1. The Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–986.
Google Scholar | Crossref | Medline | ISI2. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group . Epidemiology of Diabetes Interventions and Complications (EDIC): Design and implementation of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 1999; 22: 99–111.
Google Scholar | Crossref | Medline | ISI3. Nathan, DM, DCCT/EDIC Research Group. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care 2014; 37(1): 9–16. doi: 10.2337/dc13-2112. PMID: 24356592.
Google Scholar | Crossref | Medline | ISI4. Mendez, CE, Mok, KT, Ata, A, et al. Increased glycemic variability is independently associated with length of stay and mortality in noncritically ill hospitalized patients. Diabetes Care 2013; 36(12): 4091–4097. doi: 10.2337/dc12-2430. PMID: 24170754.
Google Scholar | Crossref | Medline | ISI5. Gerbaud, E, Darier, R, Montaudon, M, et al. Glycemic variability is a powerful independent predictive factor of midterm major adverse cardiac events in patients with diabetes with acute coronary syndrome. Diabetes Care 2019; 42(4): 674–681. doi: 10.2337/dc18-2047. PMID: 30728222.
Google Scholar | Crossref | Medline6. Goto, A, Arah, OA, Goto, M, et al. Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis. BMJ 2013; 347: f4533. doi: 10.1136/bmj.f4533.
Google Scholar | Crossref | Medline7. Zinman, B, Marso, SP, Christiansen, E, LEADER Publication Committee on behalf of the LEADER Trial Investigators, et al. Hypoglycemia, cardiovascular outcomes, and death: the LEADER experience. Diabetes Care 2018; 41(8): 1783–1791. doi: 10.2337/dc17-2677. PMID: 29903847.
Google Scholar | Crossref | Medline8. Pearson, SM, Whittam, B, Kulavarasalingam, K, et al. Reduction in cardiovascular mortality following severe hypoglycemia in individuals with type 2 diabetes: the role of a pragmatic and structured intervention: sintervention for community hypoglycemia. Cardiovasc Diabetol 2021; 20(1): 18.
Google Scholar | Crossref | Medline9. Battelino, T, Danne, T, Bergenstal, RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care 2019; 42(8): 1593–1603.
Google Scholar | Crossref | Medline10. Aleppo, G, Laffel, LM, Ahmann, AJ, et al. A practical approach to using trend arrows on the Dexcom G5 CGM System for the management of adults with diabetes. J Endocr Soc 2017; 1: 1445–1460.
Google Scholar | Crossref | Medline11. Ziegler, R, von Sengbusch, S, Kröger, J, et al. Therapy adjustments based on trend arrows using continuous glucose monitoring systems. J Diabetes Sci Technol 2019; 13: 763–773.
Google Scholar | SAGE Journals12. Ajjan, RA, Cummings, MH, Jennings, P, et al. Optimising use of rate-of-change trend arrows for insulin dosing decisions using the FreeStyle Libre flash glucose monitoring system. Diab Vasc Dis Res 2019; 16: 3–12.
Google Scholar | SAGE Journals | ISI13. Kudva, YC, Ahmann, AJ, Bergenstal, RM, et al. Approach to using trend arrows in the FreeStyle Libre flash glucose monitoring systems in adults. J Endocr Soc 2018; 2: 1320–1337.
Google Scholar | Crossref | Medline14. Rodacki, M, Calliari, LE, Ramalho, AC, et al. Using trend arrows in continuous glucose monitoring systems for insulin adjustment in clinical practice: Brazilian Diabetes Society Position Statement. Diabetol Metab Syndr 2021; 13: 2.
Google Scholar | Crossref | Medline15. Zhu, J, Volkening, LK, Laffel, LM. Distinct patterns of daily glucose variability by pubertal status in youth with type 1 diabetes. Diabetes Care 2020; 43: 22–28.
Google Scholar | Crossref | Medline16. Laffel, LM, Kanapka, LG, Beck, RW, et al. Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: a randomized clinical trial. JAMA 2020; 323: 2388–2396.
Google Scholar | Crossref | Medline17. Wolf, J, Kapellen, T, Stachow, R, et al. [Morning hyperglycemia in children and adolescents with type 1 diabetes and different modes of therapy: an evaluation of the DPV data pool]. Klin Padiatr 2012; 224: 471–475.
Google Scholar | Medline18. Kobayashi, K, Kobayashi, K, Mochizuki, M, et al. A role of free insulin-like growth factor-I in dawn phenomenon in children and adolescents with type 1 diabetes mellitus. Endocr J 2000; 47(Suppl): S91–S93.
Google Scholar | Crossref | Medline19. Clements, MA, Foster, NC, Maahs, DM, et al. Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry. Pediatr Diabetes 2016; 17: 327–336.
Google Scholar | Crossref | Medline | ISI20. Chiang, JL, Maahs, DM, Garvey, KC, et al. Type 1 diabetes in children and adolescents: a position statement by the American Diabetes Association. Diabetes Care 2018; 41: 2026–2044.
Google Scholar | Crossref | Medline21. Danne, T, Nimri, R, Battelino, T, et al. International consensus on use of continuous glucose monitoring. Diabetes Care 2017; 40: 1631–1640.
Google Scholar | Crossref | Medline22. Sherr, JL, Tauschmann, M, Battelino, T, et al. ISPAD clinical practice consensus guidelines 2018: diabetes technologies. Pediatr Diabetes 2018; 19(Suppl 27): 302–325.
Google Scholar | Crossref | Medline23. DiMeglio, LA, Acerini, CL, Codner, E, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes 2018; 19(Suppl 27): 105–114.
Google Scholar | Crossref | Medline24. Wright, N, Ng, SM, Agwub, JC, ACDC Guideline Development Group, et al. A practical approach to the management of continuous glucose monitoring (CGM)/real-time flash glucose scanning (FGS) in type 1 diabetes mellitus in children and young people under 18 years. Version 4. http://www.a-c-d-c.org/wp-content/uploads/2012/08/CGM-FGS-Practical-Approach-ACDC-Guideline-3.pdf (accessed April 2021).
Google Scholar25. Aleppo, G, Webb, K. Continuous glucose monitoring integration in clinical practice: a stepped guide to data review and interpretation. J Diabetes Sci Technol 2019; 13: 664–673.
Google Scholar | SAGE Journals26. Matthaei, S, Antuña Dealaiz, R, Bosi, E, et al. Consensus recommendations for the use of ambulatory glucose profile in clinical practice. Br J Diabetes Vasc Dis 2014; 14: 153–157.
Google Scholar | Crossref27. Hirsch, IB, Nardacci, E, Verderese, CA. Flash Continuous glucose monitoring: implications for use of continuous data in daily diabetes management. Diabetes Spectr 2019; 32: 355–367.
Google Scholar | Crossref | Medline28. Bailey, T, Bode, BW, Christiansen, MP, et al. The performance and usability of a factory-calibrated flash glucose monitoring system. Diabetes Technol Ther 2015; 17(11): 787–794.
Google Scholar | Crossref | Medline | ISI29. van Beers, CAJ, DeVries, JH, Kleijer, SJ, et al. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial. Lancet Diabetes Endocrinol 2016; 4: 893–902.
Google Scholar | Crossref | Medline | ISI30. Beck, RW, Riddlesworth, TD, Ruedy, K, et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med 2017; 167: 365–374.
Google Scholar | Crossref | Medline31. Al Hayek, AA, Robert, AA, Al Dawish, MA. Acceptability of the freestyle libre flash glucose monitoring system: the experience of young patients with type 1 diabetes. Clin Med Insights Endocrinol Diabetes 2020; 13: 1179551420910122.
Google Scholar | SAGE Journals | ISI32. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group . Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care 2010; 33: 17–22.
Google Scholar | Crossref | Medline | ISI33. Lind, M, Polonsky, W, Hirsch, IB, et al. Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial. JAMA 2017; 317: 379–387.
Google Scholar | Crossref | Medline | ISI34. Deeb, A, Yousef, H, Al Qahtani, N, et al. Novel ambulatory glucose-sensing technology improves hypoglycemia detection and patient monitoring adherence in children and adolescents with type 1 diabetes. J Diabetes Metab Disord 2019; 18: 1–6.
Google Scholar | Crossref | Medline35. Mazze, RS, Lucido, D, Langer, O, et al.. Ambulatory glucose profile: representation of verified self-monitored blood glucose data. Diabetes Care 1987; 10: 111–117.
Google Scholar | Crossref | Medline | ISI36. Bergenstal, RM, Ahmann, AJ, Bailey, T, et al. Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). Diabetes Technol Ther 2013; 15: 198–211.
Google Scholar | Crossref | Medline | ISI37. Brown, SA, Basu, A, Kovatchev, BP. Beyond HbA1c: using continuous glucose monitoring metrics to enhance interpretation of treatment effect and improve clinical decision-making. Diabet Med J Br Diabet Assoc 2019; 36: 679–687.
Google Scholar | Crossref | Medline38. Carlson, AL, Criego, AB, Martens, TW, et al. HbA1c: The glucose management indicator, time in range, and standardization of continuous glucose monitoring reports in clinical practice. Endocrinol Metab Clin North Am 2020; 49: 95–107.
Google Scholar | Crossref | Medline39. Ajjan, RA, Abougila, K, Bellary, S, et al. Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients. Diab Vasc Dis Res 2016; 13: 211–219.
Google Scholar | SAGE Journals | ISI40. Pandit, K . Continuous glucose monitoring. Indian J Endocrinol Metab 2012; 16(Suppl 2): S263–S266.
Google Scholar | Medline41. Bergenstal, RM, Ahmann, AJ, Bailey, T, et al. Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile. J Diabetes Sci Technol 2013; 7: 562–578.
Google Scholar | SAGE Journals42. Foster, NC, Beck, RW, Miller, KM, et al. State of type 1 diabetes management and outcomes from the T1D Exchange in 2016-2018. Diabetes Technol Ther 2019; 21: 66–72.
Google Scholar | Crossref | Medline43. Beck, RW, Hirsch, IB, Laffel, L, et al. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009; 32: 1378–1383.
Google Scholar | Crossref | Medline | ISI44. Patton, SR, Clements, MA. Psychological reactions associated with continuous glucose monitoring in youth. J Diabetes Sci Technol 2016; 10: 656–661.
Google Scholar | SAGE Journals45. Mauras, N, Beck, R, Xing, D, et al. A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years. Diabetes Care 2012; 35: 204–210.
Google Scholar | Crossref | Medline | ISI46. Tsalikian, E, Fox, L, Weinzimer, S, et al. Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes. Pediatr Diabetes 2012; 13: 301–307.
Google Scholar | Crossref | Medline |